Experience with ECMO therapy for acute respiratory distress syndrome treatment throughout the COVID-19 pandemic.

Objective: To analyze our experience with extracorporeal membrane oxygenation (ECMO) therapy for acute respiratory distress syndrome (ARDS) treatment during the COVID-19 pandemic.

Design: Retrospective, observational, single center study.

Setting: Third-level hospital in Spain.